Purdue Pharma can protect Sackler owners in opioid bankruptcy, court rules
NEW YORK, May 30 (Reuters) – Bankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company’s broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday. The New York-based 2nd U.S. Circuit Court of Appeals said that…
more “Purdue Pharma can protect Sackler owners in opioid bankruptcy, court rules” »